Evolvence Capital is a Dubai-based alternative investment firm established in 2000, focused on the Gulf region and India. Its India platform was the first independent India-focused private equity hybrid fund of funds, blending investments in underlying funds with direct co-investments in companies, and it remains a growth-stage, mid-market investor rather than a seed-stage venture fund.
What the firm backs
The Evolvence India Fund invests across sectors including consumer products and services, financial services, fintech, healthcare, technology, specialty manufacturing and precision engineering. Its hybrid model means it backs select small and mid-market private equity managers and then co-invests alongside them in their most attractive companies, aiming for diversification through fund investments and higher returns by cherry-picking co-investment opportunities. A dedicated Evolvence India Life Sciences Fund, established in 2006, provides growth capital to small and mid-sized pharmaceutical, biopharmaceutical, medical device, contract research and healthcare services businesses in India.
Fund size and cheque size
The first Evolvence India Fund reached its final close in July 2007 with commitments of US$250 million, deployed across 10 underlying funds and 8 co-investments and direct investments, with exposure to more than 120 companies in high-growth sectors in India. Its mandate split roughly 60 percent to Indian private equity funds and 40 percent to co-investments and direct investments. The third fund, Evolvence India Fund III, launched in 2019 with the same hybrid strategy and an added focus on venture-backed companies and venture funds, but its size is not publicly disclosed on the firm's official pages, and individual direct cheque sizes are not publicly disclosed there either.
Notable portfolio companies
Reported direct and co-investment names on the India platform include Captain Fresh, Veritas Finance, Renee, HomeLane and Capillary, spanning seafood supply chains, financial services, beauty, home interiors and customer engagement. Earlier fund investments included India Value Fund, IDFC Private Equity Fund and Ascent India Fund (formerly UTI Ventures), while early direct investments included Consolidated Construction Consortium and Centurion Bank of Punjab. The firm's India lead in its earlier fund years was Ajit Kumar, managing director of the Evolvence India Fund.
Partners and support beyond capital
Evolvence Capital's investors have included institutional investors, family offices, pension funds and sovereign wealth funds from Europe and the Gulf region. Post-investment, its teams work with management on strategy, operational improvement and overseas business development, drawing on a network built across India and international markets. No accelerator, credits or perks programme for early-stage founders was found in the firm's published material, which fits its growth-stage positioning.
How to apply for funding
There is no open seed-application portal for Evolvence Capital: it invests through commitments to private equity managers and through co-investments alongside them, so the realistic route for a founder is via an existing private equity backer or through a direct approach to the firm via its India platform at evolvenceindia.com. Founders should only pursue this route at growth stage, with revenues and a mid-market scale story, since the firm's mandate is expansion capital for companies that already have traction, not pre-revenue experimentation.
Why it matters for founders
For a growth-stage Indian company, Evolvence Capital offers something most venture funds cannot: a hybrid investor that can back your fund and co-invest directly, with Gulf and European institutional capital behind it and a two-decade record in Indian mid-market growth.